BLUE BIRD CORP (BLBD) Stock Fundamental Analysis

NASDAQ:BLBD • US0953061068

61 USD
+0.48 (+0.79%)
At close: Feb 20, 2026
61 USD
0 (0%)
After Hours: 2/20/2026, 8:18:58 PM
Fundamental Rating

6

Taking everything into account, BLBD scores 6 out of 10 in our fundamental rating. BLBD was compared to 130 industry peers in the Machinery industry. BLBD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. BLBD has a correct valuation and a medium growth rate. With these ratings, BLBD could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • BLBD had positive earnings in the past year.
  • In the past year BLBD had a positive cash flow from operations.
  • In multiple years BLBD reported negative net income over the last 5 years.
  • In multiple years BLBD reported negative operating cash flow during the last 5 years.
BLBD Yearly Net Income VS EBIT VS OCF VS FCFBLBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

1.2 Ratios

  • BLBD's Return On Assets of 20.20% is amongst the best of the industry. BLBD outperforms 98.46% of its industry peers.
  • BLBD's Return On Equity of 47.81% is amongst the best of the industry. BLBD outperforms 97.69% of its industry peers.
  • BLBD's Return On Invested Capital of 31.20% is amongst the best of the industry. BLBD outperforms 99.23% of its industry peers.
  • BLBD had an Average Return On Invested Capital over the past 3 years of 29.27%. This is significantly above the industry average of 10.17%.
  • The 3 year average ROIC (29.27%) for BLBD is below the current ROIC(31.20%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 20.2%
ROE 47.81%
ROIC 31.2%
ROA(3y)15.41%
ROA(5y)6.73%
ROE(3y)58.56%
ROE(5y)N/A
ROIC(3y)29.27%
ROIC(5y)N/A
BLBD Yearly ROA, ROE, ROICBLBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

  • The Profit Margin of BLBD (8.65%) is better than 70.00% of its industry peers.
  • In the last couple of years the Profit Margin of BLBD has grown nicely.
  • BLBD's Operating Margin of 11.46% is in line compared to the rest of the industry. BLBD outperforms 59.23% of its industry peers.
  • In the last couple of years the Operating Margin of BLBD has grown nicely.
  • The Gross Margin of BLBD (20.97%) is worse than 69.23% of its industry peers.
  • BLBD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.46%
PM (TTM) 8.65%
GM 20.97%
OM growth 3YN/A
OM growth 5Y35.18%
PM growth 3YN/A
PM growth 5Y44.13%
GM growth 3Y65.07%
GM growth 5Y13.39%
BLBD Yearly Profit, Operating, Gross MarginsBLBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15 20

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BLBD is creating value.
  • Compared to 1 year ago, BLBD has less shares outstanding
  • Compared to 5 years ago, BLBD has more shares outstanding
  • The debt/assets ratio for BLBD has been reduced compared to a year ago.
BLBD Yearly Shares OutstandingBLBD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
BLBD Yearly Total Debt VS Total AssetsBLBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • BLBD has an Altman-Z score of 6.92. This indicates that BLBD is financially healthy and has little risk of bankruptcy at the moment.
  • BLBD has a better Altman-Z score (6.92) than 87.69% of its industry peers.
  • BLBD has a debt to FCF ratio of 0.55. This is a very positive value and a sign of high solvency as it would only need 0.55 years to pay back of all of its debts.
  • BLBD has a Debt to FCF ratio of 0.55. This is amongst the best in the industry. BLBD outperforms 91.54% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that BLBD is not too dependend on debt financing.
  • BLBD has a better Debt to Equity ratio (0.31) than 62.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 0.55
Altman-Z 6.92
ROIC/WACC3.38
WACC9.24%
BLBD Yearly LT Debt VS Equity VS FCFBLBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • BLBD has a Current Ratio of 1.81. This is a normal value and indicates that BLBD is financially healthy and should not expect problems in meeting its short term obligations.
  • BLBD's Current ratio of 1.81 is on the low side compared to the rest of the industry. BLBD is outperformed by 61.54% of its industry peers.
  • BLBD has a Quick Ratio of 1.21. This is a normal value and indicates that BLBD is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.21, BLBD perfoms like the industry average, outperforming 47.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.21
BLBD Yearly Current Assets VS Current LiabilitesBLBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 28.08% over the past year.
  • Measured over the past years, BLBD shows a very strong growth in Earnings Per Share. The EPS has been growing by 39.87% on average per year.
  • Looking at the last year, BLBD shows a quite strong growth in Revenue. The Revenue has grown by 11.61% in the last year.
  • Measured over the past years, BLBD shows a quite strong growth in Revenue. The Revenue has been growing by 10.98% on average per year.
EPS 1Y (TTM)28.08%
EPS 3YN/A
EPS 5Y39.87%
EPS Q2Q%8.7%
Revenue 1Y (TTM)11.61%
Revenue growth 3Y22.73%
Revenue growth 5Y10.98%
Sales Q2Q%6.12%

3.2 Future

  • Based on estimates for the next years, BLBD will show a small growth in Earnings Per Share. The EPS will grow by 4.42% on average per year.
  • BLBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.93% yearly.
EPS Next Y0.46%
EPS Next 2Y6.43%
EPS Next 3Y4.42%
EPS Next 5YN/A
Revenue Next Year4.19%
Revenue Next 2Y4.2%
Revenue Next 3Y4.48%
Revenue Next 5Y5.93%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLBD Yearly Revenue VS EstimatesBLBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
BLBD Yearly EPS VS EstimatesBLBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

6

4. Valuation

4.1 Price/Earnings Ratio

  • BLBD is valuated correctly with a Price/Earnings ratio of 13.65.
  • BLBD's Price/Earnings ratio is rather cheap when compared to the industry. BLBD is cheaper than 92.31% of the companies in the same industry.
  • BLBD is valuated rather cheaply when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 12.27 indicates a correct valuation of BLBD.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BLBD indicates a rather cheap valuation: BLBD is cheaper than 95.38% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of BLBD to the average of the S&P500 Index (28.02), we can say BLBD is valued rather cheaply.
Industry RankSector Rank
PE 13.65
Fwd PE 12.27
BLBD Price Earnings VS Forward Price EarningsBLBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • BLBD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BLBD is cheaper than 89.23% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BLBD indicates a rather cheap valuation: BLBD is cheaper than 92.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.85
EV/EBITDA 9.46
BLBD Per share dataBLBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BLBD does not grow enough to justify the current Price/Earnings ratio.
  • BLBD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)29.85
PEG (5Y)0.34
EPS Next 2Y6.43%
EPS Next 3Y4.42%

0

5. Dividend

5.1 Amount

  • BLBD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BLUE BIRD CORP

NASDAQ:BLBD (2/20/2026, 8:18:58 PM)

After market: 61 0 (0%)

61

+0.48 (+0.79%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners113.59%
Inst Owner Change1.41%
Ins Owners0.81%
Ins Owner Change2.92%
Market Cap1.93B
Revenue(TTM)1.50B
Net Income(TTM)129.75M
Analysts82.86
Price Target65.03 (6.61%)
Short Float %17.03%
Short Ratio11.73
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.62%
Min EPS beat(2)20.09%
Max EPS beat(2)25.16%
EPS beat(4)3
Avg EPS beat(4)16.38%
Min EPS beat(4)-0.8%
Max EPS beat(4)25.16%
EPS beat(8)7
Avg EPS beat(8)30.67%
EPS beat(12)11
Avg EPS beat(12)59.19%
EPS beat(16)12
Avg EPS beat(16)-79.92%
Revenue beat(2)2
Avg Revenue beat(2)2.88%
Min Revenue beat(2)0.25%
Max Revenue beat(2)5.51%
Revenue beat(4)3
Avg Revenue beat(4)2.03%
Min Revenue beat(4)-0.95%
Max Revenue beat(4)5.51%
Revenue beat(8)5
Avg Revenue beat(8)3.11%
Revenue beat(12)9
Avg Revenue beat(12)4.96%
Revenue beat(16)12
Avg Revenue beat(16)7.06%
PT rev (1m)0%
PT rev (3m)4.08%
EPS NQ rev (1m)-5.57%
EPS NQ rev (3m)-14.61%
EPS NY rev (1m)0%
EPS NY rev (3m)1.03%
Revenue NQ rev (1m)-6.64%
Revenue NQ rev (3m)-8.3%
Revenue NY rev (1m)-0.58%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 13.65
Fwd PE 12.27
P/S 1.29
P/FCF 11.85
P/OCF 10.34
P/B 7.1
P/tB 9.12
EV/EBITDA 9.46
EPS(TTM)4.47
EY7.33%
EPS(NY)4.97
Fwd EY8.15%
FCF(TTM)5.15
FCFY8.44%
OCF(TTM)5.9
OCFY9.67%
SpS47.46
BVpS8.59
TBVpS6.69
PEG (NY)29.85
PEG (5Y)0.34
Graham Number29.39
Profitability
Industry RankSector Rank
ROA 20.2%
ROE 47.81%
ROCE 42.19%
ROIC 31.2%
ROICexc 76.78%
ROICexgc 120.5%
OM 11.46%
PM (TTM) 8.65%
GM 20.97%
FCFM 10.85%
ROA(3y)15.41%
ROA(5y)6.73%
ROE(3y)58.56%
ROE(5y)N/A
ROIC(3y)29.27%
ROIC(5y)N/A
ROICexc(3y)58.87%
ROICexc(5y)N/A
ROICexgc(3y)104.89%
ROICexgc(5y)N/A
ROCE(3y)39.57%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y47.59%
ROICexc growth 3YN/A
ROICexc growth 5Y50.42%
OM growth 3YN/A
OM growth 5Y35.18%
PM growth 3YN/A
PM growth 5Y44.13%
GM growth 3Y65.07%
GM growth 5Y13.39%
F-Score7
Asset Turnover2.33
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 0.55
Debt/EBITDA 0.45
Cap/Depr 151.15%
Cap/Sales 1.58%
Interest Coverage 26.47
Cash Conversion 99.4%
Profit Quality 125.35%
Current Ratio 1.81
Quick Ratio 1.21
Altman-Z 6.92
F-Score7
WACC9.24%
ROIC/WACC3.38
Cap/Depr(3y)101.02%
Cap/Depr(5y)87.95%
Cap/Sales(3y)1.14%
Cap/Sales(5y)1.2%
Profit Quality(3y)226.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.08%
EPS 3YN/A
EPS 5Y39.87%
EPS Q2Q%8.7%
EPS Next Y0.46%
EPS Next 2Y6.43%
EPS Next 3Y4.42%
EPS Next 5YN/A
Revenue 1Y (TTM)11.61%
Revenue growth 3Y22.73%
Revenue growth 5Y10.98%
Sales Q2Q%6.12%
Revenue Next Year4.19%
Revenue Next 2Y4.2%
Revenue Next 3Y4.48%
Revenue Next 5Y5.93%
EBIT growth 1Y27.81%
EBIT growth 3YN/A
EBIT growth 5Y50.02%
EBIT Next Year30.97%
EBIT Next 3Y13.03%
EBIT Next 5YN/A
FCF growth 1Y80.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.98%
OCF growth 3YN/A
OCF growth 5Y119.48%

BLUE BIRD CORP / BLBD FAQ

Can you provide the ChartMill fundamental rating for BLUE BIRD CORP?

ChartMill assigns a fundamental rating of 6 / 10 to BLBD.


What is the valuation status for BLBD stock?

ChartMill assigns a valuation rating of 6 / 10 to BLUE BIRD CORP (BLBD). This can be considered as Fairly Valued.


Can you provide the profitability details for BLUE BIRD CORP?

BLUE BIRD CORP (BLBD) has a profitability rating of 7 / 10.


What are the PE and PB ratios of BLUE BIRD CORP (BLBD) stock?

The Price/Earnings (PE) ratio for BLUE BIRD CORP (BLBD) is 13.65 and the Price/Book (PB) ratio is 7.1.


Can you provide the expected EPS growth for BLBD stock?

The Earnings per Share (EPS) of BLUE BIRD CORP (BLBD) is expected to grow by 0.46% in the next year.